Pulmatrix, Inc. Files 8-K: Material Agreement, Control Changes
Ticker: PULM · Form: 8-K · Filed: Nov 13, 2024 · CIK: 1574235
Sentiment: neutral
Topics: material-agreement, change-of-control, officer-director-changes
TL;DR
Pulmatrix just filed an 8-K detailing a major new deal and changes in control. Big stuff happening.
AI Summary
Pulmatrix, Inc. announced on November 13, 2024, that it entered into a material definitive agreement. The company also reported changes in control and updates regarding its officers and directors, including compensatory arrangements. This filing also includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate actions at Pulmatrix, Inc., including a new material agreement and potential shifts in control, which could impact the company's strategic direction and shareholder value.
Risk Assessment
Risk Level: medium — The filing indicates significant corporate events like changes in control and material definitive agreements, which can introduce uncertainty and potential risks.
Key Numbers
- 20241113 — Filing Date (The date the 8-K was filed and the earliest event reported.)
Key Players & Entities
- Pulmatrix, Inc. (company) — Registrant
- November 13, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36199 (company_id) — SEC File Number
- 46-1821392 (tax_id) — IRS Employer Identification No.
- 945 Concord Street (address) — Business and Mail Address
FAQ
What is the nature of the material definitive agreement entered into by Pulmatrix, Inc.?
The filing states that Pulmatrix, Inc. entered into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What specific changes in control of Pulmatrix, Inc. are reported?
The filing indicates that there were changes in control of the registrant, but the specific details of these changes are not elaborated upon in the provided text.
What are the key updates regarding Pulmatrix, Inc.'s officers and directors?
The filing mentions the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers, but specific names and details are not in the provided text.
When was this 8-K filing submitted?
The 8-K filing was submitted on November 13, 2024.
What is Pulmatrix, Inc.'s former company name?
Pulmatrix, Inc.'s former company name was Ruthigen, Inc., with a date of name change on April 11, 2013.
Filing Stats: 4,425 words · 18 min read · ~15 pages · Grade level 17.5 · Accepted 2024-11-13 09:00:56
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PULM The NASDAQ Stock Mar
- $2.5 m — nt to the Merger Agreement) will exceed $2.5 million, subject to certain adjustments a
- $10.00 — n exercise price per share greater than $10.00 per share, in each case, in accordance
- $10.5 million — ssumes (i) a valuation for Pulmatrix of $10.5 million and (ii) a valuation for Cullgen of $28
- $280.0 million — ion and (ii) a valuation for Cullgen of $280.0 million. The Exchange Ratio is also based on th
- $420,000 — red to pay Cullgen a termination fee of $420,000, and in certain other circumstances, Cu
- $2,800,000 — y Pulmatrix a termination fee of either $2,800,000 or $8,400,000. At the Effective Time, t
- $8,400,000 — termination fee of either $2,800,000 or $8,400,000. At the Effective Time, the board of di
Filing Documents
- form8-k.htm (8-K) — 86KB
- ex2-1.htm (EX-2.1) — 862KB
- ex10-1.htm (EX-10.1) — 78KB
- ex10-2.htm (EX-10.2) — 53KB
- ex10-3.htm (EX-10.3) — 132KB
- ex99-1.htm (EX-99.1) — 48KB
- ex99-2.htm (EX-99.2) — 24KB
- ex99-3.htm (EX-99.3) — 30KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- ex99-1_002.jpg (GRAPHIC) — 9KB
- ex99-2_001.jpg (GRAPHIC) — 720KB
- ex99-2_002.jpg (GRAPHIC) — 1743KB
- ex99-2_003.jpg (GRAPHIC) — 1160KB
- ex99-2_004.jpg (GRAPHIC) — 1071KB
- ex99-2_005.jpg (GRAPHIC) — 982KB
- ex99-2_006.jpg (GRAPHIC) — 868KB
- ex99-2_007.jpg (GRAPHIC) — 831KB
- ex99-2_008.jpg (GRAPHIC) — 858KB
- ex99-2_009.jpg (GRAPHIC) — 720KB
- ex99-2_010.jpg (GRAPHIC) — 1149KB
- ex99-2_011.jpg (GRAPHIC) — 1136KB
- ex99-2_012.jpg (GRAPHIC) — 864KB
- ex99-2_013.jpg (GRAPHIC) — 888KB
- ex99-2_014.jpg (GRAPHIC) — 629KB
- ex99-2_015.jpg (GRAPHIC) — 1114KB
- ex99-2_016.jpg (GRAPHIC) — 1007KB
- ex99-2_017.jpg (GRAPHIC) — 1044KB
- ex99-2_018.jpg (GRAPHIC) — 868KB
- ex99-2_019.jpg (GRAPHIC) — 901KB
- ex99-2_020.jpg (GRAPHIC) — 652KB
- ex99-2_021.jpg (GRAPHIC) — 1300KB
- ex99-2_022.jpg (GRAPHIC) — 1031KB
- ex99-2_023.jpg (GRAPHIC) — 884KB
- ex99-2_024.jpg (GRAPHIC) — 893KB
- ex99-2_025.jpg (GRAPHIC) — 596KB
- ex99-2_026.jpg (GRAPHIC) — 1005KB
- ex99-2_027.jpg (GRAPHIC) — 1015KB
- ex99-2_028.jpg (GRAPHIC) — 841KB
- ex99-2_029.jpg (GRAPHIC) — 888KB
- ex99-2_030.jpg (GRAPHIC) — 1032KB
- ex99-2_031.jpg (GRAPHIC) — 877KB
- ex99-2_032.jpg (GRAPHIC) — 1062KB
- ex99-2_033.jpg (GRAPHIC) — 366KB
- 0001493152-24-044986.txt ( ) — 44360KB
- pulm-20241113.xsd (EX-101.SCH) — 3KB
- pulm-20241113_lab.xml (EX-101.LAB) — 33KB
- pulm-20241113_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pulmatrix, Inc. Date: November 13, 2024 By: /s/ Peter Ludlum Peter Ludlum Interim Chief Executive Officer and Interim Chief Financial Officer